Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Find news

35 of 349 news items, newest first.

Free to read, “May need a subscription” and “Archived copy”: what they mean

Whether an article is free to read is a guess, not a test of your access. Each item is one of three:

  • No label: free to read (304 of 349). The publisher’s page marks it free, or the outlet publishes free to read: Medical Xpress, ScienceDaily, NIH (incl. NIA and PMC), Alzheimer's Association, Alzheimer's News Today, NPR, Alzheimer's Disease International, or a .gov site.
  • May need a subscription (11 of 349). The publisher’s own page marks the article as not free to read, or — when the page says nothing — the outlet sells subscriptions: The New York Times, STAT, Scientific American, The Washington Post, The Wall Street Journal, Financial Times, The Economist, Bloomberg, The Atlantic, The New Yorker, Wired, Los Angeles Times, The Boston Globe, The Times, The Telegraph, New Scientist, Endpoints News, Science. Each badge says which.
  • “Free to read? Not known” (34 of 349). The outlet is on neither list and its page said nothing. We do not call these paywalled.

Archived copy links go to a copy the Internet Archive (web.archive.org) saved, dated the day it was saved. We show one only where the Internet Archive reported a working saved copy when we checked; an archived copy of a subscription article sometimes shows only its opening. 265 of 349 items have one.

New AI technology can provide rapid and reliable dementia diagnosis

Medical Xpress Diagnosis

Researchers at Örebro University have developed two new AI models that can analyze the brain's electrical activity and accurately distinguish between healthy individuals and patients with dementia, including Alzheimer's disease.

Why it matters: Researchers developed AI models analyzing brain electrical activity to distinguish healthy individuals from dementia and Alzheimer's patients.

Read at Medical Xpress → Archived copy (28 Nov 2025), Internet Archive

New method to track progression of Alzheimer's, related dementias based on metabolic, vascular brain changes

Medical Xpress Diagnosis

Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a person's stage of dementia based on neurovascular and metabolic changes. They recently published their findings in Alzheimer's & Dementia.

Why it matters: Indiana University researchers developed a highly sensitive diagnostic predicting dementia stages based on neurovascular and metabolic changes.

Read at Medical Xpress → Archived copy (22 Nov 2025), Internet Archive

FDA Clears First Blood Test Used in Diagnosing Alzheimer's Disease

FDA Diagnosis

The FDA granted 510(k) clearance to Fujirebio's Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio test, the first blood test cleared to help diagnose Alzheimer's in adults 55 and older with signs of cognitive decline. In FDA's review, positive results correctly identified amyloid plaques 91.7% of the time and negative results correctly ruled them out 97.3% of the time.

Why it matters: A simple blood draw can now help identify amyloid plaques without a spinal tap or PET scan, potentially speeding diagnosis and lowering costs, though FDA stressed it isn't a stand-alone diagnostic test.

Read at FDA → Archived copy (10 Oct 2026), Internet Archive

Quest Diagnostics Launches New AD-Detect Blood Test to Aid in Confirming Alzheimer's Disease

Quest Diagnostics Diagnosis

Quest Diagnostics launched a new AD-Detect Abeta42/40 and p-tau217 blood test nationwide (except New York), combining two biomarkers into a proprietary 'Likelihood Score' that showed about 89% positive/negative predictive values in studies presented at the 2025 AAN meeting.

Why it matters: Expands commercial, direct-to-clinician access to blood-based Alzheimer's biomarker testing through one of the largest U.S. lab networks, at lower cost than PET scans or spinal taps.

Free to read? Not known for this outlet.

Read at Quest Diagnostics → Archived copy (17 Apr 2026), Internet Archive

Difficulty managing bills may signal early dementia

NIH National Institute on Aging Diagnosis

Missed mortgage and credit card payments may signal early cognitive decline years before a dementia diagnosis, according to an NIA-funded study.

Why it matters: Difficulty managing bills and missed payments may signal early cognitive decline years before a formal dementia diagnosis.

Read at NIH National Institute on Aging → Archived copy (21 Feb 2025), Internet Archive